Autolus Therapeutics plc (AUTL) Insider Trading

Last 12 months

Insiders sold $16k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. U.S. CCO & Country Gen Manager Cintia Piccina sold $16k on Sep 2, 34% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market

−$16k

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

None

in the last two years

Get an email when AUTL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Sep 2	Cintia Piccina U.S. CCO & Country Gen Manager	SoldNo plan	6,713	$2.34	$16k	34%	Form 4

Sep 2No plan
Cintia Piccina
U.S. CCO & Country Gen Manager · sold 6,713 at $2.34
$16k
34% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch AUTL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Biological Products, (No Diagnostic Substances)

AGENAgenus Inc.

IPSCCentury Therapeutics, Inc.

KYMRKymera Therapeutics Inc.

STROSutro Biopharma, Inc.

FDMT4D Molecular Therapeutics, Inc.

RGNXRegenxbio Inc.

DNAGinkgo Bioworks Holdings Inc.

MGTXMeiraGTx Holdings plc

Spot a number that looks wrong? Check it in AUTL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing AUTL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.